Institutional Review Board Statement
The iReAct study was conducted in accordance with the Declaration of Helsinki and approved by the ‘Ethics Committee of the Medical Faculty, University of Tübingen’ (reference number: 882/2017BO1). The study was retrospectively registered in the German Clinical Trials Register on 12 June 2019 (DRKS00017446).